Chicago Partners Investment Group LLC Lowers Stock Position in HCA Healthcare, Inc. $HCA

Chicago Partners Investment Group LLC reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 49.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 1,761 shares of the company’s stock after selling 1,713 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in HCA Healthcare were worth $830,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in HCA. Palisade Asset Management LLC purchased a new position in shares of HCA Healthcare during the third quarter worth $26,000. Holos Integrated Wealth LLC acquired a new position in HCA Healthcare during the 4th quarter worth about $29,000. Ares Financial Consulting LLC acquired a new position in HCA Healthcare in the 4th quarter valued at about $31,000. Cedar Mountain Advisors LLC acquired a new stake in shares of HCA Healthcare during the first quarter worth about $33,000. Finally, JPL Wealth Management LLC acquired a new position in shares of HCA Healthcare in the third quarter valued at approximately $33,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Trading Up 1.8%

Shares of HCA Healthcare stock opened at $385.71 on Friday. The company has a fifty day simple moving average of $393.51 and a 200-day simple moving average of $457.65. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The stock has a market cap of $85.57 billion, a price-to-earnings ratio of 13.26, a PEG ratio of 1.25 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same quarter in the prior year, the company earned $6.45 EPS. The business’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 29.77 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were issued a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on HCA shares. JPMorgan Chase & Co. decreased their price target on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research report on Tuesday, May 19th. Oppenheimer decreased their target price on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Raymond James Financial set a $528.00 price target on HCA Healthcare in a research report on Tuesday, July 7th. Wells Fargo & Company cut their target price on shares of HCA Healthcare from $436.00 to $428.00 and set an “equal weight” rating on the stock in a research note on Monday. Finally, Barclays lowered their price target on shares of HCA Healthcare from $427.00 to $402.00 and set an “equal weight” rating for the company in a report on Thursday. Fourteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $486.14.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Some analysts remain constructive, with one Seeking Alpha piece arguing HCA’s recent underperformance may already reflect the biggest policy and margin concerns, and that the stock could be set up for a rebound if fundamentals stabilize.
• Neutral Sentiment: Barclays lowered its price target on HCA Healthcare from $427 to $402 and kept an equal-weight rating, signaling a more cautious near-term view even though the new target still implies modest upside from current levels. Barclays Cuts HCA Price Target
• Neutral Sentiment: Several articles noted that HCA’s stock still looks discounted relative to its long-term earnings power, but valuation arguments may be offset by growing concerns around reimbursement pressure and insurance coverage losses.
• Negative Sentiment: HCA cut its 2026 earnings outlook after reporting that federal policy changes, a worsening payer mix, and more uninsured patients could reduce profits by roughly $1 billion, raising concerns about margin compression and slower growth. HCA Cuts 2026 Earnings Forecast
• Negative Sentiment: Reports also highlighted a $400 million hit linked to policy changes and weaker earnings quality, since part of the quarterly beat was helped by a one-time Medicaid payment rather than underlying operating strength.
• Negative Sentiment: Labor and contract issues at one HCA hospital added another headline risk, though this appears less material than the company’s earnings and policy-related pressures.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.